-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Drug Evaluation: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pridopidine in the pharmacological treatment of Huntingtons disease
Martin Michl, Katharina Schnopfhagen, Raphael M Bonelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Global Health Technologies Coalition present report to US government
News and Views: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation